Jitka Kuncová, Jitka Svíglerová, Zbynek Tonar, Jana Slavíková
Index: Auton. Neurosci. 121(1-2) , 7-15, (2005)
Full Text: HTML
The changes in concentrations of neuropeptide Y (NPY), norepinephrine and epinephrine were investigated in the rat hearts 1, 2, 4, 6, 9 and 12 months after administration of streptozotocin (STZ; 65 mg/kg i.v.). About 30% of diabetic animals displayed symptoms of partial spontaneous recovery, i.e. decreasing blood glucose levels and increasing insulin concentrations in the plasma and pancreas. NPY concentrations in the atria of diabetic rats did not differ from those in age-matched control rats 1, 2, 4, 6 months in the right atria and even 9 months after STZ in the left atria. However, uncompensated diabetes led to a significant decrease in NPY levels 9 and 12 months after STZ administration in the right and left atria, respectively. In the ventricles, NPY concentrations were significantly decreased 6 months after the onset of diabetes. Interestingly, partial spontaneous recovery of diabetes was associated with increased NPY levels in the atria. Myocardial norepinephrine concentrations increased 1 month after STZ and then declined reaching approximately 60% of the respective control values 12 months after the onset of the disease. Partial spontaneous recovery of diabetes had no effect on norepinephrine concentrations. Myocardial epinephrine concentrations did not differ from those found in controls till month 9 of the disease and they became significantly lower at month 12. Partial recovery of diabetes resulted in epinephrine concentrations not differing from the control values at month 12 of diabetes. Regarding to preferential localization of norepinephrine in the sympathetic postganglionic fibers and that of NPY also in intrinsic ganglion neurons, intrinsic neuronal circuits seem to be less susceptible to STZ-induced damage than extrinsic nerves and they might be able to recover after amelioration of diabetes.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
norethandrolone
CAS:52-78-8 |
C20H30O2 |
[Tumors of the liver secondary to androgen therapy. Apropos ...
1987-01-01 [Chir. Pediatr. 28(2) , 97-101, (1987)] |
Heart lesions associated with anabolic steroid abuse: compar...
2009-07-01 [Exp. Toxicol. Pathol. 61(4) , 317-23, (2009)] |
In vitro study methodologies to investigate genetic aspects ...
2013-01-01 [J. Neural Transm. Gen. Sect. 120(1) , 131-9, (2013)] |
Hepatic tumours during androgen therapy in Fanconi anaemia.
1993-08-01 [Eur. J. Pediatr. 152(8) , 691-3, (1993)] |
[Effects of weakly androgenic anabolic steroids on growth in...
1985-04-01 [Arch. Fr. Pediatr. 42(4) , 265-71, (1985)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved